Literature DB >> 16493485

The serpin proteinase inhibitor 8: an endogenous furin inhibitor released from human platelets.

Julie Leblond1, Marie-Hélène Laprise, Simon Gaudreau, Francine Grondin, Walter Kisiel, Claire M Dubois.   

Abstract

The cornerstone of hemostasis is the ability of the organism to limit the enzymatic processes involved, thereby avoiding thrombosis. For this, anticoagulant systems in place involve serpins, such as PAI-1 and antithrombin III, which bind to their targeted serine proteases and limit their period of activity. We have previously identified the serine protease furin as a platelet-derived enzyme with an intrinsic role in platelet functions. We now report that furin enzymatic activity decreased rapidly following platelet activation, corresponding with the increase in formation of a high 180 M(r) SDS-stable complex composed of furin and the PI8 serpin. PI8 is shown to be a platelet-derived constituent, synthesized by megakaryocytes and stored in platelets prior to its release. Immunoprecipitation and purification of the PI8-furin complex confirmed their direct interaction and indicates that one of the roles of PI8 is to inhibit furin enzymatic activity. Furthermore, our findings demonstrate the inhibitory capacity of exogenous PI8 in platelet aggregation assays. The finding that PI8 is released by platelets and controls functional responses suggests a role for this serpin in platelet-regulated pathophysiological responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493485     DOI: 10.1160/TH05-08-0561

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

Review 1.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

2.  Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras.

Authors:  Gonzalo Izaguirre; Lixin Qi; Mary Lima; Steven T Olson
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

3.  Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?

Authors:  Jan Fritzsche; Philipp Stawowy
Journal:  J Mol Med (Berl)       Date:  2011-11       Impact factor: 4.599

4.  Specific and Selective Inhibitors of Proprotein Convertases Engineered by Transferring Serpin B8 Reactive-Site and Exosite Determinants of Reactivity to the Serpin α1PDX.

Authors:  Gonzalo Izaguirre; Marcelino Arciniega; Andrea G Quezada
Journal:  Biochemistry       Date:  2019-03-08       Impact factor: 3.162

5.  Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.

Authors:  Carolin Langnau; Anne-Katrin Rohlfing; Sarah Gekeler; Manina Günter; Simone Pöschel; Álvaro Petersen-Uribe; Philippa Jaeger; Alban Avdiu; Tobias Harm; Klaus-Peter Kreisselmeier; Tatsiana Castor; Tamam Bakchoul; Dominik Rath; Meinrad Paul Gawaz; Stella E Autenrieth; Karin Anne Lydia Mueller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-29       Impact factor: 8.311

6.  Modifying the substrate specificity of Carcinoscorpius rotundicauda serine protease inhibitor domain 1 to target thrombin.

Authors:  Pankaj Kumar Giri; Xuhua Tang; Saravanan Thangamani; Rajesh T Shenoy; Jeak Ling Ding; Kunchithapadam Swaminathan; J Sivaraman
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

7.  Proprotein convertase subtilisin/kexin type 3 promotes adipose tissue-driven macrophage chemotaxis and is increased in obesity.

Authors:  Kai Kappert; Heike Meyborg; Jan Fritzsche; Daniel Urban; Janine Krüger; Ernst Wellnhofer; Ulrich Kintscher; Eckart Fleck; Philipp Stawowy
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

8.  Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map.

Authors:  Nguyen T Nguyen; Xiaolin Zhang; Cathy Wu; Richard A Lange; Robert J Chilton; Merry L Lindsey; Yu-Fang Jin
Journal:  PLoS Comput Biol       Date:  2014-03-20       Impact factor: 4.475

9.  Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases.

Authors:  Fatma Sfaxi; Nathalie Scamuffa; Claude Lalou; Jia Ma; Peter Metrakos; Géraldine Siegfried; Hermann Ragg; Andreas Bikfalvi; Fabien Calvo; Abdel-Majid Khatib
Journal:  Oncotarget       Date:  2014-06-30

Review 10.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.

Authors:  Yuan Huang; Chan Yang; Xin-Feng Xu; Wei Xu; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2020-08-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.